Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.40 -0.09 (-2.58%)
As of: Oct 1, 2026 · 2:25 PM EDT

Galmed Pharmaceuticals (EOCN) Change in Net Loans (2022 - 2023)

Updated

Galmed Pharmaceuticals' Change in Net Loans was $1.68 million in Q1 2023, up 11.7% from the prior quarter.

Analysis

Galmed Pharmaceuticals (EOCN) Change in Net Loans (2022 - 2023) Analysis & Trends

For FY2022, Change in Net Loans at Galmed Pharmaceuticals came in at $1.5 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Net Loans (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Galmed Pharmaceuticals 406,071.97 406,071.97 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1.68 Mn
Dec 31, 2022 1.50 Mn
API Access

Galmed Pharmaceuticals Change in Net Loans API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-net-loans&ticker=EOCN&period=max&api_key=YOUR_API_KEY